Literature DB >> 1691449

A frame-shift mutation in the cystic fibrosis gene.

M B White1, J Amos, J M Hsu, B Gerrard, P Finn, M Dean.   

Abstract

Cystic fibrosis (CF) is a common recessive lethal genetic disorder, affecting 1 in 1,600 Caucasians. The disease causes defective regulation of chloride-ion transport in exocrine cells. Although in all CF families the disease is linked to a locus on chromosome 7q31, there is clinical heterogeneity in the severity of the disease and the age at which it is diagnosed. CF is caused by mutations in the CF transmembrane conductance regulator (CFTR) gene. A three-nucleotide deletion (delta F508) causing the loss of a phenylalanine residue in the tenth exon of the CFTR gene has been found on 70% of CF chromosomes. We have now characterized a CF family in which neither parent of the affected individual carries the common mutation, and identified a two-nucleotide insertion in the CF allele of the mother. The mutation introduces a termination codon in exon 13 of the CFTR gene at residue 821, and is predicted to result in the production of a severely truncated nonfunctional protein.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1691449     DOI: 10.1038/344665a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  37 in total

1.  Disruption of the cystic fibrosis transmembrane conductance regulator gene in embryonic stem cells by gene targeting.

Authors:  R Ratcliff; M J Evans; J Doran; B J Wainwright; R Williamson; W H Colledge
Journal:  Transgenic Res       Date:  1992-07       Impact factor: 2.788

2.  Incidence and expression of the N1303K mutation of the cystic fibrosis (CFTR) gene.

Authors:  L Osborne; G Santis; M Schwarz; K Klinger; T Dörk; I McIntosh; M Schwartz; V Nunes; M Macek; J Reiss
Journal:  Hum Genet       Date:  1992-08       Impact factor: 4.132

3.  Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene.

Authors:  B S Kerem; J Zielenski; D Markiewicz; D Bozon; E Gazit; J Yahav; D Kennedy; J R Riordan; F S Collins; J M Rommens
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

4.  The incidence of different cystic fibrosis mutations in the Scottish population: effects on prenatal diagnosis and genetic counselling.

Authors:  A E Shrimpton; I McIntosh; D J Brock
Journal:  J Med Genet       Date:  1991-05       Impact factor: 6.318

5.  Mechanisms of insertional mutagenesis in human genes causing genetic disease.

Authors:  D N Cooper; M Krawczak
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

6.  A mutation in the second nucleotide binding fold of the cystic fibrosis gene.

Authors:  L Osborne; R Knight; G Santis; M Hodson
Journal:  Am J Hum Genet       Date:  1991-03       Impact factor: 11.025

7.  A cluster of highly polymorphic dinucleotide repeats in intron 17b of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Authors:  J Zielenski; D Markiewicz; F Rininsland; J Rommens; L C Tsui
Journal:  Am J Hum Genet       Date:  1991-12       Impact factor: 11.025

8.  A child, homozygous for a stop codon in exon 11, shows milder cystic fibrosis symptoms than her heterozygous nephew.

Authors:  H Cuppens; P Marynen; C De Boeck; F De Baets; E Eggermont; H Van den Berghe; J J Cassiman
Journal:  J Med Genet       Date:  1990-11       Impact factor: 6.318

9.  BLIP-II Employs Differential Hotspot Residues To Bind Structurally Similar Staphylococcus aureus PBP2a and Class A β-Lactamases.

Authors:  Carolyn J Adamski; Timothy Palzkill
Journal:  Biochemistry       Date:  2017-02-16       Impact factor: 3.162

10.  CF2603/4delT, a new frameshift mutation in exon 13 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Authors:  B Ezquieta; J Molano
Journal:  Hum Genet       Date:  1993-07       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.